Pharmafile Logo

Strategies to enhance the provider and patient EAP experience

April 30, 2026 |  

Expanded access programs (EAPs) play a multifaceted role in the drug development life cycle, serving as a critical bridge between clinical trials and commercial availability.

- PMLiVE

 

To read the whitepaper in full, please see here: Enhancing the EAP Experience for HCPs & Patients | Uniphar

This content was provided by Uniphar

Documents for download:

Company Details

 Latest Content from  Uniphar 

Uniphar Rebrands On Demand Business to Uniphar Global Sourcing, Strengthening Global Pharmaceutical Offering

Dublin, Ireland 16th July 2025 – Leading global healthcare services provider, Uniphar, has launched Uniphar | Global Sourcing, a new identity for its On Demand business that strengthens its position...

Uniphar Secures 10th Cell and Gene Therapy Project

[Dublin, April 17th 2025] Uniphar, a global leader in pharmaceutical and medtech solutions has announced the launch of its 10th cell and gene therapy (CGT) project. The milestone reinforces Uniphar’s...

Uniphar Expands Global Footprint with Three New Facilities in the USA, Netherlands and Ireland

[Dublin, 05 February 2025] Global partner to pharmaceutical and medtech manufacturers, Uniphar, is expanding its international presence with the launch of three new, state-of-the-art facilities, strategically positioned across key global...

Uniphar appoints industry leader, Isaac Batley, as Global Head of Scientific Communications

Isaac Batley, an experienced CEO with 35 years’ experience within healthcare and pharmaceutical communications, joins Uniphar to spearhead its medical communications division.

From molecule to market and beyond: Uniphar announces extended global commercialization platform

Healthcare services business, Uniphar, has developed its full-service offering that harnesses Uniphar’s 57 years in the industry delivering specialist services to more than 200 international clients across 180 countries.